NanoEntek, Inc. (KOSDAQ:039860)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,350.00
+1,690.00 (29.86%)
At close: Apr 29, 2026
Market Cap279.98B +175.5%
Revenue (ttm)38.13B +25.2%
Net Income1.58B -55.9%
EPS47.00 -60.5%
Shares Out38.09M
PE Ratio156.38
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,458,065
Average Volume977,110
Open5,620.00
Previous Close5,660.00
Day's Range5,560.00 - 7,350.00
52-Week Range3,015.00 - 9,390.00
Beta0.73
RSI67.33
Earnings DateMay 14, 2026

About NanoEntek

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic... [Read more]

Industry Laboratory Analytical Instruments
Founded 1987
Employees 97
Stock Exchange KOSDAQ
Ticker Symbol 039860
Full Company Profile

Financial Performance

In 2025, NanoEntek's revenue was 38.13 billion, an increase of 25.16% compared to the previous year's 30.46 billion. Earnings were 1.58 billion, a decrease of -55.93%.

Financial Statements